טוען...
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
BACKGROUND: Nephrotic syndrome is a disorder characterized by proteinuria, hypoalbuminemia and dyslipidemia. Low-dose alternate-day steroid regimen is the standard of care. In case of relapse or significant adverse events, steroid-sparing agents may be used. This analysis was aimed at assessing the...
שמור ב:
| הוצא לאור ב: | Ital J Pediatr |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943005/ https://ncbi.nlm.nih.gov/pubmed/27405390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0271-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|